Where
Dedication
Delivers
  • Excellence
  • Value
  • Quality
  • Efficiency
  • Excellence

Welcome to Rezon Bio

Europe’s biologics CDMO for cost-efficient, end-to-end development and manufacturing

Integrated biologics CDMO services in one place. From cell line development to commercial GMP manufacturing: faster, leaner, and built around your program.

Capabilities That Fit Today’s Needs

Rapid scale-up with extensive capacity

Ensuring reliable delivery and a seamless transition from clinic to market

End-To-end services, enabled by partnerships

Led by scientists 
with proven experience

Our tech transfer expertise and strategic partnerships for fill/finish enable us to deliver “ready to fill” solutions

Discover our services

From cell line development to clinical and commercial GMP manufacturing

Process development & characterization

Scalable upstream and downstream biologics processes built for robustness, optimized for biosimilars and new biological entities (NBEs) from lab to commercial scale. 

Read more

Analytical capabilities

Phase-appropriate, method-qualified testing for product quality and release

Read more

GMP manufacturing

Flexible single-use GMP capacity at clinical and commercial scale, inspection-ready and approved by FDA and EMA. 

Read more

Quality

Systems aligned with regulatory requirements, confirmed by successful inspections and focused on lifecycle aspects

Read more
About Rezon Bio

Driven by science. Powered by partnerships. A European biologics CDMO built on proven GMP manufacturing excellence and a biosimilar heritage

We deliver cost-efficient, end-to-end European biologics CDMO services, helping biotech and pharmaceutical companies accelerate development and commercialization with uncompromising quality.
Rezon Bio in numbers

Certified excellence in biotech manufacturing. Trusted by global regulators and powered by world-class talent.

Number of employees, 80% of our workforce with higher education degrees

Employees (10% PhD)

>1100 employees

Last year’s batch output

Production

73 batches produced in 2025

Batch success rate achieved in 2025

Batch success

95% batch succces rate

Number of successfully passed audits

Audits

35+ EMA, FDA, MHRA, ANVISA

Experience in biologics development

Experience

16 years of operation

Tech transfers since the beginning of operations

Transfers

12 tech transfers

Nationalities represented by our professionals

Team

22 nationalities
Discover our GMP Facilities

Built for clinical to commercial scale

Our two GMP-certified facilities in Poland provide phase-integrated biologics services, from cell line development to commercial supply, approved by FDA, EMA, and ANVISA.

Commercial scale

The large, state-of-the-art GMP facility offers full technical development and commercial-scale manufacturing with 2,000L bioreactors.

Clinical development & manufacturing

Full technical development and medium-scale manufacturing center, with expertise in clinical development, regulatory affairs, and IP management.

Ready to get started?

Partner with a European biologics CDMO dedicated to deliver program success

  1. Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence
  2. Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success